HealthcareServices

Global Panic Attack Treatment Industry Insights: Key Trends and Growth Estimates

February 27, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the panic attack treatment market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Panic Attack Treatment Market be in 2030 compared with 2026?

The panic attack treatment market size has seen rapid growth in recent years. It is expected to grow from $3.58 billion in 2025 to $4.21 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.6%. The expansion observed in the historic period can be attributed to factors such as limited awareness surrounding panic attack treatments, a strong reliance on in-person therapy, the high cost associated with specialized medications, a fragmented mental healthcare infrastructure, and the low adoption rate of digital therapy tools.

The panic attack treatment market size is poised for substantial growth in the upcoming years. It is forecast to reach $7.97 billion by 2030, driven by a compound annual growth rate (CAGR) of 17.3%. This anticipated growth throughout the forecast period stems from factors such as the increasing adoption of telehealth platforms, the advancement of virtual reality and digital therapeutics, the rising prevalence of anxiety and panic disorders, innovations in personalized medicine, and the expansion of online pharmacy and hospital distribution channels. Prominent trends observed during the forecast period involve the rising adoption of telepsychiatry and mobile health applications, the integration of virtual reality therapy for panic disorders, an increasing application of neurofeedback and biofeedback techniques, the development of personalized medication plans, and the expansion of mental healthcare centers and hospital services.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24356&type=smp

What Drivers Are Guiding Growth Patterns In The Panic Attack Treatment Market?

The rising incidence of anxiety is anticipated to boost expansion within the panic attack treatment market in the future. Anxiety is defined as a mental health disorder marked by ongoing feelings of apprehension, unease, and dread, frequently presenting with physical signs like agitation, accelerated heart rate, and impaired focus. Contemporary societal pressures contribute to elevated anxiety levels, imposing continuous requirements for output, economic security, and social achievement, thereby limiting opportunities for relaxation or emotional recuperation. Treatment for panic attacks tackles anxiety through providing efficacious remedies to ease symptoms, enhance emotional health, and assist individuals in reclaiming mastery over their lives via tailored and prompt interventions. To illustrate, in May 2024, data from the American Psychiatric Association (APA), a US-based medical specialty organization representing psychiatrists across the nation, indicated that a rising proportion of U.S. adults are reporting increased anxiety, with 43% in 2024 noting higher anxiety levels, an increase from 37% in 2023 and 32% in 2022. Consequently, the growing occurrence of anxiety is fueling the panic attack treatment market.

How Is The Panic Attack Treatment Market Divided Into Segments?

The panic attack treatment market covered in this report is segmented –

1) By Treatment Type: Cognitive Behavioral Therapy (CBT), Medications, Other Treatment Types

2) By Drug Class: Antidepressants, Anti-Anxiety Drugs, Calcitonin Gene-Related Peptide (CGRP) Antagonists, Other Drug Classes

3) By Route Of Administration: Oral, Sublingual, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By Application: Hospitals, Mental Healthcare Centers, Other Applications

Subsegments:

1) By Cognitive Behavioral Therapy (CBT): Exposure Therapy, Dialectical Behavior Therapy (DBT), Acceptance And Commitment Therapy (ACT), Mindfulness-Based Cognitive Therapy (MBCT), Rational Emotive Behavior Therapy (REBT)

2) By Medications: Beta Blockers, Buspirone, Anticonvulsants, Atypical Antipsychotics, Herbal And Natural Supplements

3) By Other Treatment Types: Telepsychiatry, Biofeedback And Neurofeedback, Virtual Reality Therapy, Mobile Health Applications, Support Groups And Counseling Services

What Trends Are Reshaping The Dynamics Of The Panic Attack Treatment Market?

Companies operating within the panic attack treatment market are prioritizing advancements in medical technology, such as digital anxiety relief platforms, to improve the management of anxiety and panic attacks through readily available, technology-driven methods. Digital anxiety relief platforms are technology-based applications or services designed to assist individuals in managing and diminishing anxiety via tools like guided meditation, cognitive behavioral therapy modules, mood tracking, and relaxation exercises. For example, in October 2024, CalmiGo, a US-based mental health startup, introduced CalmiGo Plus, an advanced digital platform created to help users more effectively manage anxiety and panic attacks. This platform features a patented, sensor-based exhaler device and a supplementary mobile application that employs gamification and personalized therapeutic strategies to enhance mental health outcomes. This innovation allows users to experience immediate, drug-free relief while simultaneously monitoring their progress, indicating a substantial leap forward in accessible and data-driven anxiety treatment solutions.

Which Major Industry Participants Are Leading The Panic Attack Treatment Market Growth?

Major companies operating in the panic attack treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Lundbeck A/S, Torrent Pharmaceuticals Ltd., Merck & Co Inc., Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co Ltd, Boehringer Ingelheim International GmbH, Allergan plc, Alkermes plc, Jazz Pharmaceuticals plc, Bayer AG, Amgen Inc., Cipla Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/panic-attack-treatment-global-market-report

Which Region Currently Holds The Largest Share Of The Panic Attack Treatment Market?

North America was the largest region in the panic attack treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic attack treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Panic Attack Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24356&type=smp

Browse Through More Reports Similar to the Global Panic Attack Treatment Market 2026, By The Business Research Company

Catalepsy Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/catalepsy-treatment-global-market-report

Generalized Anxiety Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Migraine Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795